Page 1 of 1

They must ask themselves whether

Posted: Thu Feb 13, 2025 4:40 am
by asimj1
All the information collected must be managed and accessed by sponsors, contract research organizations (CROs), and site staff throughout the course of a trial. The continuous influx of information and the proliferation of digital touchpoints can lead to data interoperability challenges, information overload, and mismanagement of patient data that are essential for the success of clinical trials.

An added challenge is finding the time and iran whatsapp number data resources to thoroughly analyze all the data. This does not only affect informed decision-making but impacts the site staff’s work and the patient outcomes, and can lead to deviations in the results and longer timelines for the clinical trial. This is where AI holds tremendous benefits. However, it is crucial to recognize that AI is not a plug-and-play solution.

Organizations must first establish efficient processes to fully harness the power of AI. they have a strategy for digitization and automation, how it will impact data access and maintenance in relation to their current systems, and how to maintain compliance and privacy standards.